این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Basic Medical Sciences، جلد ۲۹، شماره ۲، صفحات ۲۷۱-۲۷۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی An in vivo evaluation of the antifibrotic potential of inulin against bile duct ligation-induced liver fibrosis
چکیده انگلیسی مقاله Objective(s): Hepatic fibrosis is a major cause of liver-related mortality worldwide. This study evaluated the hepatoprotective and antifibrotic effects of inulin, a natural polysaccharide, in a rat model of cholestasis induced by bile duct ligation (BDL).Materials and Methods: Thirty male Wistar rats (230–250 g) were randomly divided into six groups: control, sham, inulin (200 mg/kg), BDL, and BDL+ inulin (100 and 200 mg/kg). Inulin was orally administered for 30 days after BDL. Serum liver enzyme levels, bilirubin, and lipid profiles were measured. Liver tissues were analyzed for oxidative stress markers (GPx, MDA), fibrogenic mediators (TGF-β1, α-SMA) via immunohistochemistry, and FXR levels by ELISA. Histological changes were evaluated by ELISA and Masson’s trichrome staining.Results: At 200 mg/kg, inulin significantly reversed the BDL-induced increases in serum liver enzymes (AST, ALT, and ALP), total bilirubin, and cholesterol (P<0.001 vs BDL group). Hepatic GPx and FXR levels were significantly increased (P<0.001 vs BDL group), while MDA levels were decreased (P<0.001 vs BDL group). Inulin markedly suppressed the expression of TGF-β1 and α-SMA (P<0.01 vs BDL group). Histopathological evaluation showed notable improvement in liver architecture, with reduced fibrosis and necrosis (P<0.001 vs BDL group). Conclusion: These findings suggest that inulin may exert antifibrotic effects through its anti-oxidant activity, ultimately reducing the expression of fibrogenic markers. This study presents strong histological evidence to support the hepatoprotective role of inulin.
کلیدواژه‌های انگلیسی مقاله α-actins smooth muscle, Anti-Oxidants, Bile duct ligation, cholestasis, Farnesoid X receptor, Factor-β1, Inulin, Liver fibrosis, Transforming growth
نویسندگان مقاله | Yasaman Habibian-Fard
Department of Pharmacology and Toxicology, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran


| Mahsa Ale-Ebrahim
Department of Physiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran


| Parvaneh Mohseni-Moghaddam
Department of Physiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran


| Shadi Sarahroodi
Department of Pharmacology and Toxicology, Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran


| Pejman Mortazavi
Department of Pathology, Faculty of Specialized Veterinary Science and Research Branch, Islamic Azad University, Tehran, Iran
نشانی اینترنتی https://ijbms.mums.ac.ir/article_27299.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات